Lotus Pharmaceutical Co Ltd (1795) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.057x

Based on the latest financial reports, Lotus Pharmaceutical Co Ltd (1795) has a cash flow conversion efficiency ratio of 0.057x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$1.35 Billion ≈ $42.51 Million USD) by net assets (NT$23.78 Billion ≈ $749.20 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Lotus Pharmaceutical Co Ltd (1795) net asset quality to measure how much of total assets are equity-financed.

Lotus Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2009–2025)

This chart illustrates how Lotus Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Lotus Pharmaceutical Co Ltd (1795) cash flow quality to evaluate the quality of earnings relative to operating cash generation.

Lotus Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Lotus Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Qinchuan Machine Tool & Tool Group Share Co Ltd SHE:000837	0.028x
Suzhou Gold Mantis Construction Decoration Co Ltd SHE:002081	0.029x
Shenzhen Jufei Optoelectronics SHE:300303	0.002x
Black Box Limited NSE:BBOX	0.059x
Gempharmatech Co. Ltd. A SHG:688046	N/A
E-Mart KO:139480	0.069x
Guangdong High Dream Intellectualized Machinery Co Ltd Class A SHE:300720	0.022x
Collective Mining Ltd. NYSE:CNL	-0.158x

Annual Cash Flow Conversion Efficiency for Lotus Pharmaceutical Co Ltd (2009–2025)

The table below shows the annual cash flow conversion efficiency of Lotus Pharmaceutical Co Ltd from 2009 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Lotus Pharmaceutical Co Ltd worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	NT$23.78 Billion ≈ $749.20 Million	NT$7.48 Billion ≈ $235.72 Million	0.315x	+8.27%
2024-12-31	NT$21.18 Billion ≈ $667.30 Million	NT$6.15 Billion ≈ $193.91 Million	0.291x	+212.04%
2023-12-31	NT$17.33 Billion ≈ $546.10 Million	NT$1.61 Billion ≈ $50.86 Million	0.093x	-65.28%
2022-12-31	NT$13.87 Billion ≈ $436.91 Million	NT$3.72 Billion ≈ $117.18 Million	0.268x	+2380.88%
2021-12-31	NT$11.07 Billion ≈ $348.73 Million	NT$119.66 Million ≈ $3.77 Million	0.011x	-95.15%
2020-12-31	NT$8.75 Billion ≈ $275.53 Million	NT$1.95 Billion ≈ $61.39 Million	0.223x	+469.83%
2019-12-31	NT$7.74 Billion ≈ $243.97 Million	NT$302.81 Million ≈ $9.54 Million	0.039x	-62.31%
2018-12-31	NT$7.68 Billion ≈ $241.98 Million	NT$796.98 Million ≈ $25.11 Million	0.104x	+34.84%
2017-12-31	NT$7.70 Billion ≈ $242.50 Million	NT$592.29 Million ≈ $18.66 Million	0.077x	-47.82%
2016-12-31	NT$8.36 Billion ≈ $263.42 Million	NT$1.23 Billion ≈ $38.85 Million	0.147x	+19.48%
2015-12-31	NT$8.73 Billion ≈ $275.06 Million	NT$1.08 Billion ≈ $33.95 Million	0.123x	+205.33%
2014-12-31	NT$8.81 Billion ≈ $277.59 Million	NT$-1.03 Billion ≈ $-32.53 Million	-0.117x	-81.88%
2013-12-31	NT$1.49 Billion ≈ $46.87 Million	NT$-95.84 Million ≈ $-3.02 Million	-0.064x	+24.60%
2012-12-31	NT$637.28 Million ≈ $20.08 Million	NT$-54.45 Million ≈ $-1.72 Million	-0.085x	+33.24%
2011-12-31	NT$596.05 Million ≈ $18.78 Million	NT$-76.29 Million ≈ $-2.40 Million	-0.128x	-239.89%
2010-12-31	NT$646.95 Million ≈ $20.38 Million	NT$59.19 Million ≈ $1.86 Million	0.091x	-53.31%
2009-12-31	NT$456.73 Million ≈ $14.39 Million	NT$89.50 Million ≈ $2.82 Million	0.196x	--

About Lotus Pharmaceutical Co Ltd

TW:1795 Taiwan Drug Manufacturers - Specialty & Generic

Market Cap

$1.45 Billion

NT$45.99 Billion TWD

Market Cap Rank

#7227 Global

#215 in Taiwan

Share Price

NT$175.00

Change (1 day)

+1.16%

52-Week Range

NT$173.00 - NT$363.00

All Time High

NT$363.00